How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,912 results for

physical therapy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to Radioiodine Therapy of Benign Thyroid Diseases (Supplement)

EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to Radioiodine Therapy of Benign Thyroid Diseases (Supplement) 1 European Journal of Nuclear Medicine and Molecular Imaging EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases H. Hänscheid 1 , C. Canzi 2 , W.Eschner 3 , G.Flux 4 , M. Luster 5 , L.Strigari 6 , M (...) . Lassmann 1 1 Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany; 2 Department of Nuclear Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy; 3 Department of Nuclear Medicine, University of Cologne, Cologne, Germany; 4 Joint Department of Physics, Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Sutton, UK; 5 Department of Nuclear Medicine, University of Ulm, Ulm, Germany; 6 Laboratory of Medical Physics and Expert Systems

2013 European Association of Nuclear Medicine

102. EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to Radioiodine Therapy of Benign Thyroid Diseases

Series “Standard Op- erational Procedures for Pre-Therapeutic Dosimetry” (SOP) istoproviderecommendationstoscientistsandclinicianson howtoperformpretherapeuticpatient-specificabsorbeddose assessments thus adding supplementary and comprehensive G. Flux, L. Strigari and M. Lassmann are members of the EANM Dosimetry Committee; W. Eschner is a member of the EANM Physics Committee; and M. Luster is a member of the EANM Therapy Committee. Electronicsupplementarymaterial Theonline versionof thisarticle (doi (...) of Physics, Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Sutton, UK M. Luster Department of Nuclear Medicine, University of Ulm, Ulm, Germany L. Strigari Laboratory of Medical Physics and Expert Systems, National Cancer Institute Regina Elena, Rome, Italy Eur J Nucl Med Mol Imaging DOI 10.1007/s00259-013-2387-xinformationtothecorrespondingmedicallyorienteddisease- specific guidelines provided by the Therapy Committee of the EANM. The main objective of radioiodine ( 131 I) therapy

2013 European Association of Nuclear Medicine

103. EANM procedure guidelines for therapy of benign thyroid disease

A. Definitions 1. 131 I is a beta-emitting radionuclide with a physical half- life of 8.02 days, a principal gammaray of 364 keVand a principal beta particle with a maximum energy of 0.61 MeV, average energy of 0.192 MeV and an average range in tissue of 0.4 mm. 2. Therapy in this context means the oral or intravenous administration of 131 I as sodium iodide. 3. Benign condition in this context means Graves’ disease (diffuse toxic goitre), toxic or nontoxic goitre and solitary hyperfunctioning thyroid nodule (...) be undertaken by appropriately trained medical staff with supporting nursing staff and an available medical physics expert. Physicians responsible for treating patients should have a general knowledge of the pathophysiology and natural history of the respective diseases, should be familiar with alternative forms of therapy, and should be able to liaise closely with other physicians involved in managing the patients. Clinicians involved in unsealed source therapy must also be knowledgeable about

2010 European Association of Nuclear Medicine

104. Treatment of HIV-1 positive adults with antiretroviral therapy

Treatment of HIV-1 positive adults with antiretroviral therapy © 2016 British HIV Association _________________________________________________________________________________________________________________________ British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 (2016 interim update) NHS Evidence has accredited the process used by the British HIV Association (BHIVA) to produce guidelines. Accreditation is valid for five years from (...) July 2012 and is applicable to guidance produced using the processes described in the British HIV Association (BHIVA) Guideline Development Manual. More information on accreditation can be viewed at www.nice.org.uk/accreditation August 2016 1 BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 (2016 interim update) Writing Group Laura Waters Chair N Ahmed, B Angus, M Boffito, M Bower, D Churchill, D Dunn, S Edwards, C Emerson, S Fidler, †M Fisher, R Horne, S

2014 British HIV Association

105. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy

EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy GUIDELINES EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy Michael Lassmann &Heribert Hänscheid & Carlo Chiesa &Cecilia Hindorf &Glenn Flux & Markus Luster Published online: 20 May 2008 # EANM 2008 (...) at the moment. There might be different procedures that also lead to the same or similar results. This paper is the first in a series of disease- and patient- specific “how to” procedures intended to summarise the methodology for assessing absorbed dose in targeted radionuclide therapy. The aim of the paper is to provide supplementary and comprehensive information to the corresponding medically oriented disease-specific guide- lines provided by the “Therapy Committee” of the EANM. This SOP gives

2008 European Association of Nuclear Medicine

106. Recommendations for Aromatase inhibitors as adjuvant endocrine therapy for post-menopausal women with hormone receptor-positive early breast cancer

Recommendations for Aromatase inhibitors as adjuvant endocrine therapy for post-menopausal women with hormone receptor-positive early breast cancer Recommendations?for?Aromatase?inhibitors?as adjuvant?endocrine?therapy for?post-menopausal?women?with?hormone?receptor-positive?early?breast?cancer JULY?2006?| Incorporates?published?evidence?to?May?2005 A?CLINICAL?PRACTICE?GUIDELINE?DEVELOPED?BY?THE?NATIONAL?BREAST?CANCER?CENTRE* (NBCC*) This?document?supplements?guideline?recommendation?19?about (...) ).?In?July?2011,?NBOCC?amalgamated?with?Cancer Australia?to?form?a?single?national?agency,?Cancer?Australia,?to?provide?leadership?in?cancer?control?and?improve outcomes?for?Australians?affected?by?cancer. Purpose To?provide?statements?and?recommendations,?based?on?the?best?available?evidence,?about?the?use?of? aromatase inhibitors?as? adjuvant? endocrine?therapy?for?post-menopausal?women?with?hormone?receptor-positive?early? invasive breast?cancer. Endorsed?by: Background Aromatase?inhibitors

2006 Cancer Australia

107. Complementary and alternative therapies

by cancer patients and needs unmet by conventional medicine, helplessness and lower scores on emotional and social functioning scales. 12 Other reasons reported by women with breast cancer in Australia and overseas for using complementary and alternative therapies, include improving physical and emotional wellbeing and quality of life, boosting the immune system and seeking to reduce side effects. 7, 8 Discussing the use of complementary and alternative therapies It has been reported in an Australian (...) Complementary and alternative therapies Complementary and alternative therapies | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2010 Published: 2004 Complementary and alternative therapies Complementary and alternative therapies are commonly used by cancer patients. There is evidence to support the effectiveness of some complementary therapies and for such therapies, clinicians should discuss their potential benefits and use alongside conventional

2010 Cancer Australia

108. Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy

Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login (...) Purchase options Connect person_outline Login keyboard_arrow_down Individual Login Purchase options menu search Advertisement close Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy Mathis Grossmann, Emma J Hamilton, Christopher Gilfillan, Damien Bolton, Daryl Lim Joon and Jeffrey D Zajac Med J Aust 2011; 194 (6): 301-306. || doi: 10.5694/j.1326-5377.2011.tb02979.x Published online: 21 March 2011 Topics Abstract Androgen deprivation

2011 Clinical Practice Guidelines Portal

109. Lipid lowering therapy for adults with diabetes

not be perceived as failure of therapy, as any reduction toward target is likely to be beneficial. Diet and lifestyle Lifestyle modification focusing on fat intake, weight loss (if indicated) and increased physical activity has been shown to improve the lipid profile in patients with diabetes. 3 Lifestyle interventions including dietary modification, should support lipid management in all people. 4 Diet should be low in total fat, cholesterol, saturated fat and transunsaturated fat. 3,6 Pharmacological (...) Lipid lowering therapy for adults with diabetes clinical practice Debra rowett BPharm, for the Department of Veterans Affairs, Veterans’ Medicines Advice and Therapeutics Education Services (Veterans’ MATES) Writing Group. Josephine crockett BPharm, for the Department of Veterans Affairs, Veterans’ Medicines Advice and Therapeutics Education Services (Veterans’ MATES) Writing Group. leslie Jackowski BSc(Hons), MBBS, Sansom Institute, University of South Australia, for the Department of Veterans

2008 The Royal Australian College of General Practitioners

110. Evidence based guidelines for the nutritional management of patients receiving radiation therapy

Nutrition intervention (dietary counselling and/or supplements) during and post radiation therapy improves patient‐centred outcomes (quality of life, physical function and patient satisfaction). NHMRC grade of recommendation: B Nutrition support via gastrostomy/jejunostomy for head and neck cancer patients during radiation therapy improves patient‐centred outcomes (quality of life) compared with oral diet alone. NHMRC grade of recommendation: C Clinical question What nutrition follow up should patients (...) in . The goal of the nutritional management of patients receiving radiation therapy is to improve dietary intake and maintain quality of life and physical function. It is not anticipated that nutrition therapy will impact on tumour response or survival (level I evidence; level IV evidence ) although the evidence is conflicting (level IV evidence , ). Future research in this area should measure loco‐regional control and mortality as outcomes. The goals and outcomes of nutrition intervention will be dependent

Full Text available with Trip Pro

2008 Clinical Practice Guidelines Portal

111. The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy

The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy - Canadian Journal of Cardiology Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 28 (...) , Issue 3, Pages 270–287 The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy x Stella S. Daskalopoulou Affiliations Division of General Internal Medicine, McGill University, Montreal, Québec, Canada Correspondence Corresponding author: Dr Stella S. Daskalopoulou, McGill University, McGill University Health Centre, Montreal General Hospital, 1650 Cedar Avenue, B2.101.4, Montreal

2012 CPG Infobase

112. Cardiac Pacing and Cardiac Resynchronization Therapy

Cardiac Pacing and Cardiac Resynchronization Therapy ESCGUIDELINES 2013ESCGuidelinesoncardiacpacingandcardiac resynchronizationtherapy TheTaskForceoncardiacpacingandresynchronizationtherapyofthe EuropeanSocietyofCardiology(ESC).Developedincollaboration withtheEuropeanHeartRhythmAssociation(EHRA). Authors/TaskForceMembers:MicheleBrignole(Chairperson)(Italy) * , AngeloAuricchio(Switzerland),GonzaloBaron-Esquivias(Spain),PierreBordachar (France),GiuseppeBoriani(Italy),Ole-ABreithardt(Germany (...) resynchronization therapy † Pacemaker † Heart failure † Syncope † Atrial ?brillation Online publish-ahead-of-print 24 June 2013 TableofContents Abbreviations and acronyms . . . . . . . . . . . . . . . . . . . . . . . .2282 Abbreviations: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2282 Acronyms of the trials referenced in the recommendations or reported in the tables: . . . . . . . . . . . . . . . . . . . . . . . . . .2283 1. Preamble

2013 European Society of Cardiology

113. Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer

Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer Evidence-Based Series 2-4 Version 3 A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer Members of the Gastrointestinal Cancer Disease Site Group Evidence-based Series (EBS) 2-4 Version 3 was reviewed in 2019 and ENDORSED by the Gastrointestinal (...) Cancer Disease Site Group (See Section 4: Document Assessment and Review for details) EBS 2-4 Version 3 is comprised of 4 sections. You can access the summary and full report here: https://www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/31891 Section 1: Clinical Practice Guideline (ENDORSED) Section 2. Part 1: Evidentiary Base: Part 1. Preoperative Therapy Section 2. Part 2: Evidentiary Base: Part 2. Postoperative Therapy Section 3: EBS Development Methods and External Review Process

2019 Cancer Care Ontario

114. Compression therapy after invasive treatment of superficial veins of the lower extremities

Compression therapy after invasive treatment of superficial veins of the lower extremities Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology - Journal of Vascular Surgery: Venous and Lymphatic Disorders Email/Username: Password: Remember me Search JVS Journals Search (...) Terms Search within Search Access provided by Volume 7, Issue 1, Pages 17–28 Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology x Fedor Lurie Affiliations Jobst Vascular Institute of Promedica, Toledo, Ohio University of Michigan, Ann Arbor, Mich Correspondence

2019 American Venous Forum

115. Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients

Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients LABORATORY MEDICINE PRACTICE GUIDELINES EDITED BY LORALIE J. LANGMAN AND PAUL J. JANNETTO Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Co-Sponsored byLABORATORY MEDICINE PRACTICE GUIDELINES Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients Loralie J. Langman Committee Chair Department of Laboratory Medicine and Pathology Mayo Clinic (...) References 101 Table of ContentsLABORATORY MEDICINE PRACTICE GUIDELINES Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients 5 Executive Summary Introduction The American Association for Clinical Chemistry (AACC) Acad- emy, formerly the National Academy of Clinical Biochemistry (NACB), has developed a laboratory medicine practice guidelines (LMPG) for using laboratory tests to monitor drug therapy in pain management patients. The scope and purpose of this guideline

2018 American Academy of Pain Medicine

116. Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement

contribute to the care of physical disorders, including diabetes and obesity. Consistent advice should be provided on diet, exercise and smoking, and the psychiatric team should assume responsibility for ensuring appropriate screening is undertaken, in close liaison with other healthcare providers. Here, we outline the main findings of the consensus group. The full consensus statements for professionals and for consumers and carers are available at Antipsychotic therapy and diabetes Many case reports (...) Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset  close Individual Login Purchase options Connect person_outline Login keyboard_arrow_down Individual Login

2004 MJA Clinical Guidelines

117. The 2017 hormone therapy position statement of The North American Menopause Society

The 2017 hormone therapy position statement of The North American Menopause Society Copyright @ 2017 The North American Menopause Society. Unauthorized reproduction of this article is prohibited. POSITION STATEMENT The 2017 hormone therapy position statement of The North American Menopause Society Abstract The2017HormoneTherapyPositionStatementofTheNorthAmericanMenopauseSociety(NAMS)updatesthe 2012HormoneTherapyPositionStatementofTheNorthAmericanMenopauseSocietyandidentifiesfutureresearch needs (...) . An Advisory Panel of clinicians and researchers expert in the field of women’s health and menopause was recruited by NAMS to review the 2012 Position Statement, evaluate new literature, assess the evidence, and reach consensusonrecommendations,usingthelevelofevidencetoidentifythestrengthofrecommendationsandthequality of the evidence. The Panel’s recommendations were reviewed and approved by the NAMS Board of Trustees. Hormone therapy (HT) remains the most effective treatment for vasomotor symptoms (VMS

2017 The North American Menopause Society

118. Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning

Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning Special Article Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: An ASTRO Consensus Paper Jean L. Wright MD a , Sue S. Yom MD, PhD, MAS b , Musaddiq J. Awan MD c , Samantha Dawes CMD d, *, Benjamin Fischer-Valuck MD e , Randi Kudner MA d , Raymond Mailhot Vega MD, MPH f , George Rodrigues MD, PhD g a Johns Hopkins University, Baltimore, Maryland; b University of California, San (...) Francisco, California; c Medical College of Wisconsin, Milwaukee, Wisconsin; d American Society for Radiation Oncology, Arlington, Virginia; e Emory University, Atlanta, Georgia; f University of Florida, Jacksonville, Florida; g London Health Sciences Centre, London, ON, Canada Received 4 September 2018; revised 29 November 2018; accepted 8 December 2018 Abstract Purpose: Thecomprehensiveidenti?cationanddelineationoforgansatrisk(OARs)arevitaltothe quality of radiation therapy treatment planning

2019 American Society for Radiation Oncology

119. Home Oxygen Therapy for Children

Home Oxygen Therapy for Children Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine ');//--> Cookies Notification By browsing our website you agree to our use of , revised and . Search Menu Connect With Us Search in: American Journal of Respiratory and Critical Care Medicine > > Abstract Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline (...) Assembly on Pediatrics Show All... PubMed: Abstract Section: Background: Home oxygen therapy is often required in children with chronic respiratory conditions. This document provides an evidence-based clinical practice guideline on the implementation, monitoring, and discontinuation of home oxygen therapy for the pediatric population. Methods: A multidisciplinary panel identified pertinent questions regarding home oxygen therapy in children, conducted systematic reviews of the relevant literature

2019 American Thoracic Society

120. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search October 2019 September 2019 August 2019 July 2019 June 2019 May 2019 April 2019 March 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use (...) of cookies. Free Access article Share on Jump to Free Access article Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association , MD, FAHA , MD , MD , MD, MHS , MD, MSc , PharmD, MPH , MD, PhD , DDS , MD, FAHA , MD , MD, FAHA , MD , MD , PhD, RN and MD, FAHA PhD, FAHA Larry M. Baddour , Walter R. Wilson , Arnold S. Bayer , Vance G. FowlerJr , Imad M. Tleyjeh , Michael J. Rybak

2015 American Heart Association

Guidelines

Guidelines – filter by country